Urovant Sciences announces its partnership with Holly Robinson Peet, actress and OAB patient, as part of the Time To Go™ campaign, an OAB awareness program. The Time to Go campaign aims to highlight the impact the disease can have on patients and present options for managing OAB symptoms so that people living with OAB feel … Read more
Exact Sciences (EXAS) closed the last trading day at $67.92, down 0.67% from the previous trading session. The move was smaller than the S&P 500's 1.56% decline for the day. Elsewhere, the Dow lost 1.81% while the Tech-Nasdaq lost 4.66%. The molecular diagnostics company's shares were up 33.84% month-on-month today. Meanwhile, the medical sector was … Read more
MarketWatch News was not involved in the creation of this content. January 12, 2023 (The Expresswire). The life sciences automation market is predicted to reach several billion dollars by 2029 compared to 2022. The final report will include an analysis of the Russian-Ukrainian war and the impact of COVID-19 on the life sciences automation industry. … Read more
text size Cancer testing company Exact Sciences did not expect to report the results until the September quarter. But test seller Cologuard said sales growth in the December quarter helped boost profits earlier than expected. Sunday in Madison, Wisconsin. Revenue rose 28% to more than $550 million in the last quarter of 2022, according to … Read more
higher education January 10, 2023 The Seton Hall Health Sciences Campus, home to the College of Medical and Health Sciences and the College of Nursing, will receive $1.14 million in federal funding announced by Congressman Bill Pascrell (NJ-9), said the Senators Robert Menendez and Cory Booker. Congressman Pascrell said, "I have visited the IHS campus … Read more
© Courtesy of Benzinga New York-based Perception Neuroscience, the clinical-stage psychedelic biotechnology company Atai Life Sciences (NASDAQ: ATAI ), announced the results of its PCN-101 study of a specific R-ketamine in patients with treatment-resistant depression (TRD). Although the combination showed signs of efficacy at all time points, the study did not reach the primary endpoint … Read more
Gilead Sciences has pledged billions of dollars to Galapagos in an autoimmune disease partnership that is far from expected. But the drugmaker is not giving up on this therapeutic area and is now forming a new alliance with a new partner whose technology could offer treatments for rheumatoid arthritis and lupus. The partner is EVOQ … Read more
©PT.I Nagpur, Jan 3 (PTI) Prime Minister Narendra Modi on Tuesday laid out his vision for science for the next 25 years, urging researchers to focus on making the nation self-sufficient and transforming their knowledge to make a difference in everyone's lives. Inaugurating the 108th Indian Science Congress here, Modi emphasized strengthening scientific processes, focusing … Read more
© The Motley Fool This new drug could be a catalyst for Gilead Sciences' growth Gilead Sciences (NASDAQ:GILD) is one of the year's biggest stocks, up 17%, while the S&P 500 is down 21% over the same period. And the company may have given investors reason to remain optimistic about the stock. Health officials have … Read more
Shares of Guardian Health Sciences Inc. (NASDAQ: GHSI ) rose on Friday 12/30/22 as the stock price rose 0.76% from the previous day's close as strong buying pushed the stock up $0.15. Actively tracking price action in recent trades, the stock closed the session at $0.14, reaching a range of $0.142 to $0.151. The beta … Read more